SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,498,158 | -73.2% | 364,342 | -38.7% | 0.00% | -75.0% |
| Q2 2023 | $27,926,965 | +6.5% | 593,938 | -4.9% | 0.02% | +6.7% |
| Q1 2023 | $26,211,195 | +9.8% | 624,671 | -0.1% | 0.02% | 0.0% |
| Q4 2022 | $23,863,575 | -2.7% | 625,133 | -0.1% | 0.02% | -11.8% |
| Q3 2022 | $24,527,459 | +21.0% | 625,882 | -0.2% | 0.02% | +21.4% |
| Q2 2022 | $20,270,546 | -13.3% | 626,928 | -11.1% | 0.01% | -6.7% |
| Q1 2022 | $23,377,568 | +63.0% | 704,819 | +110.3% | 0.02% | +66.7% |
| Q4 2021 | $14,345,000 | -17.3% | 335,224 | -14.4% | 0.01% | -35.7% |
| Q3 2021 | $17,347,000 | +6.8% | 391,481 | +37.0% | 0.01% | +7.7% |
| Q2 2021 | $16,236,000 | -23.8% | 285,787 | +0.4% | 0.01% | -27.8% |
| Q1 2021 | $21,309,000 | -4.5% | 284,693 | +10.4% | 0.02% | -14.3% |
| Q4 2020 | $22,303,000 | +16.4% | 257,804 | -17.8% | 0.02% | +5.0% |
| Q3 2020 | $19,164,000 | +37.4% | 313,545 | -6.1% | 0.02% | +53.8% |
| Q2 2020 | $13,948,000 | +88.8% | 333,918 | +29.8% | 0.01% | +62.5% |
| Q1 2020 | $7,389,000 | -59.4% | 257,288 | +2.2% | 0.01% | -57.9% |
| Q4 2019 | $18,178,000 | -49.3% | 251,806 | +0.2% | 0.02% | -52.5% |
| Q3 2019 | $35,865,000 | -23.0% | 251,243 | -1.2% | 0.04% | -25.9% |
| Q2 2019 | $46,554,000 | +32.2% | 254,273 | +14.9% | 0.05% | +42.1% |
| Q1 2019 | $35,211,000 | +66.0% | 221,382 | 0.0% | 0.04% | +40.7% |
| Q4 2018 | $21,206,000 | -32.2% | 221,382 | +0.0% | 0.03% | -18.2% |
| Q3 2018 | $31,267,000 | +31.1% | 221,359 | +45.3% | 0.03% | +26.9% |
| Q2 2018 | $23,842,000 | +376.5% | 152,313 | +390.3% | 0.03% | +333.3% |
| Q1 2018 | $5,004,000 | +5.9% | 31,067 | +8.3% | 0.01% | +20.0% |
| Q4 2017 | $4,727,000 | +185.6% | 28,697 | +8.0% | 0.01% | +150.0% |
| Q3 2017 | $1,655,000 | -23.0% | 26,566 | -1.5% | 0.00% | -33.3% |
| Q2 2017 | $2,149,000 | +27.2% | 26,980 | +13.5% | 0.00% | +50.0% |
| Q1 2017 | $1,689,000 | +60.4% | 23,764 | +15.3% | 0.00% | 0.0% |
| Q4 2016 | $1,053,000 | +24.9% | 20,610 | +12.5% | 0.00% | +100.0% |
| Q3 2016 | $843,000 | +52.4% | 18,318 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $553,000 | +76.1% | 18,361 | +82.8% | 0.00% | – |
| Q1 2016 | $314,000 | -43.6% | 10,046 | +5.1% | 0.00% | -100.0% |
| Q4 2015 | $557,000 | +39.2% | 9,557 | +1.1% | 0.00% | – |
| Q3 2015 | $400,000 | -40.7% | 9,454 | +2.3% | 0.00% | -100.0% |
| Q2 2015 | $674,000 | +198.2% | 9,240 | +105.3% | 0.00% | – |
| Q1 2015 | $226,000 | +41.2% | 4,500 | +2.9% | 0.00% | – |
| Q4 2014 | $160,000 | – | 4,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |